Trans American Aquaculture (GRPS) Depreciation & Amortization (CF) (2023 - 2025)
Trans American Aquaculture (GRPS) reported Depreciation & Amortization (CF) of $4865.0 for Q1 2025, down 72.51% on a YoY basis from $17695.0 in Q1 2024, and up 114.82% quarter-over-quarter from -$32831.0 in Q4 2024.
Trans American Aquaculture (GRPS) Depreciation & Amortization (CF) (2023 - 2025) Analysis & Trends
Trans American Aquaculture has reported Depreciation & Amortization (CF) for 3 years, with the latest figure at $4865.0 in Q1 2025.
- For the quarter ending Q1 2025, Depreciation & Amortization (CF) fell 72.51% year-over-year to $4865.0; the trailing twelve-month figure through Sep 2025 stood at -$27966.0 (down 140.2% YoY), and the FY2024 full-year result was $52291.0, down 5.93% from the prior year.
- Depreciation & Amortization (CF) for Q1 2025 stood at $4865.0, up from -$32831.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $20533.0 in Q2 2023, with the low at -$32831.0 in Q4 2024.
- Historically, Depreciation & Amortization (CF) has averaged $10470.2 across 3 years, with a median of $17281.0 in 2023.
- The largest YoY upside for Depreciation & Amortization (CF) was 17.41% in 2024 against a maximum downside of 289.98% in 2024.
- Trans American Aquaculture's Depreciation & Amortization (CF) stood at $17281.0 in 2023, then sank by 289.98% to -$32831.0 in 2024, then jumped by 114.82% to $4865.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $4865.0 (Q1 2025), -$32831.0 (Q4 2024), and $17045.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4,865.00 |
| Mar 31, 2025 | 4,865.00 |
| Dec 31, 2024 | -32,831.00 |
| Dec 31, 2024 | -32,831.00 |
| Sep 30, 2024 | 17,045.00 |
| Sep 30, 2024 | 17,045.00 |
| Jun 30, 2024 | 17,551.00 |
| Jun 30, 2024 | 17,551.00 |
| Mar 31, 2024 | 17,695.00 |
| Mar 31, 2024 | 17,695.00 |
| Dec 31, 2023 | 17,281.00 |
| Dec 31, 2023 | 17,281.00 |
| Sep 30, 2023 | 14,518.00 |
| Sep 30, 2023 | 14,518.00 |
| Jun 30, 2023 | 20,533.00 |
| Jun 30, 2023 | 20,533.00 |
| Mar 31, 2023 | 17,575.00 |
| Mar 31, 2023 | 17,575.00 |